Post-essential Thrombocythemia Myelofibrosis clinical trials at UCSF

1 research study open to eligible people

DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
open to eligible people ages 18 years and up
This phase 1b/2a open-label study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and clinical activity of DISC-0974 as well as categorize the effects on hematologic response in participants with myelofibrosis or myelodysplastic syndrome and anemia.
San Francisco, California and other locations

Our lead scientists for Post-essential Thrombocythemia Myelofibrosis research studies include Jerry Lee, MD, MS.

Last updated: July 16, 2026

DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia